Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT04772079

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Conditions: Plaque Psoriasis

Sex: All

Ages: 4 Years – 18 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 153

Sponsor: Bristol-Myers Squibb

Location: Instituto de Neumonologia Y Dermatologia Ciudad Autonoma de Buenos Aires Buenos Aires

Summary

The purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in children and adolescent participants aged 4 to \

Eligibility Criteria

Inclusion Criteria * Males and females aged 12 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04772079). StuddyBuddy aggregates publicly available trial information.